Amaranth Medical grabs $20 mln in Series B financing

Amaranth Medical has raised $20 million in Series B financing. Singapore-based DCP Management was the lead investor. Existing investors Bio*One Capital, Charter Life Sciences and Phillip Capital joined new investor Venstar Capital in the round. Based in Mountain View, Calif., Amaranth Medical is a provider of medical devices.

8 October 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail